Role of locus coeruleus α1-adrenoceptors in motor activity in rats

Synapse

Volumn 54, Issue 3, 2004, Pages 164-172

  Stone, Eric A ^a,b   Lin, Yan ^a   Ahsan, Rashedul ^a   Quartermain, David ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

DSP4; Exploratory activity; Phenylephrine; Terazosin

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; PHENYLEPHRINE; TERAZOSIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; LOCUS CERULEUS; MALE; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BENZYLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXPLORATORY BEHAVIOR; IMMOBILIZATION; LOCUS COERULEUS; MALE; MEDIAL FOREBRAIN BUNDLE; MOTOR ACTIVITY; NEUROTRANSMITTER UPTAKE INHIBITORS; PHENYLEPHRINE; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 7244243773     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20074     Document Type: Article

References (65)

1. Anden NE, Strombom U, Svensson TH. 1973. Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity. Psychopharmacology 29:289-298.
2. Anlezark G, Walter D, Arbuthnott G, Crow T, Eccleston D. 1975. The relationship between noradrenaline turnover in cerebral cortex and electrical self-stimulation through electrodes in the region of locus coeruleus. J Neurochem 24:677-681.
3. Archer T, Fredriksson A, Jonsson G, Lewander T, Mohammed A, Ross S, Soderberg U. 1986. Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat. Psychopharmacology 88:141-146.
4. Aston-Jones G, Chen S, Zhu Y, Oshinsky ML. 2001. A neural circuit for circadian regulation of arousal. Nat Neurosci 4:732-738.
5. Bennett MC, Kaleta-Michaels S, Arnold M, McGaugh JL. 1990. Impairment of active avoidance by the noradrenergic neurotoxin, DSP4: attenuation by post-training epinephrine. Psychopharmacology 101:505-510.
6. Berridge CW, Dunn AJ. 1990. DSP-4-induced depletion of brain norepinephrine produces opposite effects on exploratory behavior 3 and 14 days after treatment. Psychopharmacology 100:504-508.
7. Berridge CW, Page ME, Valentino RJ, Foote SL. 1993. Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus. Neuroscience 55:381-393.
8. Berridge CW, Isaac SO, España RA. 2003. Additive wake-promoting actions of medial basal forebrain noradrenergic α1- and β-receptor stimulation. Behav Neurosci 117:350-359.
9. Boudaba C, Di S, Tasker JG. 2003. Presynaptic noradrenergic regulation of glutamate inputs to hypothalamic magnocellular neurones. J Neuroendocrinol 15:803-810.
10. Butler PD, Weiss J, Stout JC, Nemeroff CB. 1990. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion in the locus coeruleus. J Neurosci 10:176-183.
11. Chamba G, Weissmann D, Rousset C, Renaud B, Pujol JF. 1991. Distribution of alpha-1 and alpha-2 binding sites in the rat locus coeruleus. Brain Res Bull 26:185-193.
12. Chan-Palay V. 1991. Locus coeruleus and norepinephrine in Parkinson's disease. Jpn J Psychiat Neurol 45:519-521.
13. Clark FM, Proudfit HK. 1991. The projection of locus coeruleus neurons to the spinal cord in the rat determined by anterograde tracing combined with immunocytochemistry. Brain Res 538:231-245.
14. Clayton E, Rajkowski J, Cohen J, Aston-Jones G. 2003. Decision-related activation of monkey locus coeruleus neurons in a forced choice task. Proc Soc Neurosci 29:722.27.
15. Cole B, Robbins TW, Everitt BJ. 1988. Lesions of the dorsal noradrenergic bundle simultaneously enhance and reduce responsivity to novelty in a food preference test. Brain Res Rev 13:325-349.
16. Crochet S, Sakai K. 1999. Effects of microdialysis application of monoamines on the EEG and behavioural states in the cat mesopontine tegmentum. Eur J Neurosci 11:3738-3752.
17. Crochet S, Sakai K. 2003. Dopaminergic modulation of behavioral states in mesopontine tegmentum: a reverse microdialysis study in freely moving cats. Sleep 26:801-806.
18. Daftary SS, Boudaba C, Szabo K, Tasker JG. 1998. Noradrenergic excitation of magnocellular neurons in the rat hypothalamic paraventricular nucleus via intranuclear glutamatergic circuits. J Neurosci 18:10619-10628.
19. De Carvalho LP, Zornetzer SF. 1982. Enhanced responsiveness of alpha-noradrenergic receptors following discrete electrolytic lesions of the nucleus locus coeruleus: a behavioral demonstration. J Neural Transm 53:23-37.
20. De Sarro GB, Ascioti C, Froio F, Libri V, Nistico G. 1987. Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha-1 and alpha-2-adrenoceptors affect sleep and arousal mechanisms. Br J Pharmacol 90:675-685.
21. De Sarro GB, Fratta W, Giglio A, Nistico G. 1992. Electrocortical power spectrum changes induced by microinfusion of corticotropin-releasing factor into the locus coeruleus in rats. Funct Neurol 7:407-412.
22. Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S, Tassin JP. 2002. α1b-Adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22: 2873-2884.
23. 1-adrenoceptors. Eur J Pharmacol 73:221-224.
24. Ennis M, Aston-Jones G, Shiekhatter R. 1992. Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerulear excitatory amino acid neurotransmisson. Brain Res 598:185-195.
25. 2)-adrenoreceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice. Pharmacol Toxicol 67:123-131.
26. Garcia-Rill E. 1986. The basal ganglia and the locomotor regions. Brain Res Rev 11:47-63.
27. Gold PW, Goodwin FK, Chrousos GP. 1988. Clinical and biochemical manifestations of depression. N Engl J Med 319:348-353.
28. 1 adrenoceptor-mediated inhibition of group III metabotropic glutamate receptors. J Neurosci 23:6223-6231.
29. Grenhoff J, Nisell M, Ferre S, Aston-Jones G, Svensson TH. 1993. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm 93:11-25.
30. 1-Adrenergic effects on dopamine neurons recorded intracellularly in the rat midbrain slice. Eur J Neurosci 7:1707-1713.
31. Hancock AA, Buckner SA, Ireland LM, Knepper SM, Kerwin Jr JF. 1995. Actions of terazosin and its enantiomers at subtypes of alpha 1- and alpha 2-adrenoceptors in vitro. J Recept Signal Transduct Res 15:863-885.
32. Hornykiewicz O, Kish SJ. 1986. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45:19-34.
33. 2 adrenergic receptor suggests different sleep-wake state activities and roles. Neuroscience 114:517-521.
34. Ivanov A, Aston-Jones G. 1995. Extranuclear dendrites of locus coeruleus neurons: activation by glutamate and modulation of activity by alpha adrenoceptors. J Neurophysiol 74:2427-2436.
35. Jedema HP, Grace AA. 2003. Chronic exposure to cold stress alters electrophysiological properties of locus coeruleus neurons recorded in vitro. Neuropsychopharmacology 28:63-72.
36. Jones LS, Gauger LL, Davis JN. 1985. Anatomy of brain alpha-1 adrenergic receptors: in vitro autoradiography with [125-I]-heat. J Comp Neurol 231:190-208.
37. Koob G, Fray P, Iversen S. 1978. Self-stimulation at the lateral hypothalamus and locus coeruleus after specific unilateral lesions of the dopamine system. Brain Res 146:123-140.
38. Kostowski W, Plaznik A, Pudlowski O, Malatynska E. 1982. Effect of lesions of the brain noradrenergic systems on amphetamine-induced hyperthermia and locomotor stimulation. Acta Physiol Polon 33:383-387.
39. Liebman J, Hall N, Prowse J. 1982. Effect of various catecholamine receptor antagonists, muscle relaxation and physical hindrance on shuttlebox self-stimulation. Pharmacol Biochem Behav 16:785-790.
40. Lones MD, Hess EJ. 2003. Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma. Pharmacol Biochem Behav 75:209-216.
41. 2A receptor or a1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol 367:197-206.
42. Mason ST, Roberts DC, Fibiger HC. 1978. Noradrenergic influences on catalepsy. Psychopharmacology 60:53-57.
43. Mavridis M, Colpaert FC, Millan MJ. 1991. Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by a1 as compared to a2 agonists and antagonists. Brain Res 562:216-224.
44. Moore H, Rose HJ, Grace AA. 2001. Chronic cold stress reduces the spontaneous activity of ventral tegmental dopamine neurons. Neuropsychopharmacology 24:410-419.
45. Murrough J, Boss-Williams K, Emery M, Bonsall R, Weiss J. 2000. Depletion of brain norepinephrine does not reduce spontaneous ambulatory activity of rats in the home cage. Brain Res 883:125-130.
46. 1-adrenoceptor-mediated collateral excitation in the regulation of the electrical activity of locus coeruleus neurons. Neuroscience 27:921-929.
47. Nicoll RA, Malenka RC, Kauer JA. 1990. Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol Rev 70:513-565.
48. Ono H, Fukuda H. 1995. Pharmacology of descending noradrenergic systems in relation to motor function. Pharmacol Ther 68:105-112.
49. Orsini C, Buchini F, Piazza PV, Puglisi-Allegra S, Cabib S. 2004. Susceptibility to amphetamine-induced place preference is predicted by locomotor response to novelty and amphetamine in the mouse. Psychopharmacology 172:264-270.
50. Osborne PB, Vidovic M, Chieng B, Hill CE, Christie MJ. 2002. Expression of mRNA and functional alpha1-adrenoceptors that suppress the GIRK conductance in adult rat locus coeruleus neurons. Br J Pharmacol 135: 226-232.
51. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. Sydney: Academic Press.
52. Pisa M, Martin-Iverson MT, Fibiger HC. 1988. On the role of the dorsal noradrenergic bundle in learning and habituation to novelty. Pharmacol Biochem Behav 30:835-845.
53. Pycock CJ, Donaldson IM, Marsden CD. 1975. Circling behaviour produced by unilateral lesions in the region of the locus coeruleus in rats. Brain Res 97:317-329.
54. Simson PE, Weiss J. 1988. Altered activity of the locus coeruleus in an animal model of depression. Neuropsychopharmacology 1:287-295.
55. Simson PG, Weiss J, Hoffman LJ, Ambrose MJ. 1986. Reversal of behavioral depression by infusion of an alpha-2 adrenergic agonist into the locus coeruleus. Neuropharmacology 25:385-389.
56. Sqalli-Houssaini Y, Cazalets JR. 2000. Noradrenergic control of locomotor networks in the in vitro spinal cord of the neonatal rat. Brain Res 852:100-109.
57. 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice. Neuroscience 94:1245-1252.
58. 1-adrenoceptors in motor activity in mice. Synapse 49:67-76.
59. 1-adrenergic antagonist, terazosin, in the IVth ventricle in rats. Neurosci Lett 353:231-233.
60. 1-adrenergic system that regulates behavioral activation and is impaired in depression. Neuropsychopharmacology 28:1387-1399.
61. 1-adrenoceptors that regulate behavioral activation in the mouse brain. Behav Brain Res 152:167-175.
62. Tohgi H, Abe T, Takahashi S. 1993. The effects of L-threo-3,4- dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients. J Neural Transm Park Dig Dement Sect 5:27-34.
63. Weiss J, Demetrikopoulos M, West C, Bonsall R. 1996. Hypothesis linking the noradrenergic and dopaminergic systems in depression. Depression 3:225-245.
64. Williams J, Marshall K. 1987. Membrane properties and adrenergic responses in locus coeruleus neurons of young rats. J Neurosci 7:3687-3694.
65. Wu MF, Gulyani SA, Yau E, Mignot E, Phan B, Siegel JM. 1999. Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience 91:1389-1399.